Showing 1 - 10 of 4,457
. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany … current management of the condition (unmet need, Italy), the regulatory status (Orphan Designation, Germany), as well as … medicines was 63 (Germany), 459 (Italy), and 557 days (France). Conclusions: The clinical domains of the EUnetHTA framework are …
Persistent link: https://www.econbiz.de/10011942836
Persistent link: https://www.econbiz.de/10003902579
Persistent link: https://www.econbiz.de/10003361757
Persistent link: https://www.econbiz.de/10001171508
Persistent link: https://www.econbiz.de/10001244378
Persistent link: https://www.econbiz.de/10001334622
instruments and the remuneration derived therefrom are characterized by a neat division into dividend-generating equity and …, Germany, Italy and the Netherlands as well as in the relevant tax treaties and EU Directives. Moreover, based on selected … options that are in line with the dichotomous debt-equity framework, as he/she suggests the coordination of either tax …
Persistent link: https://www.econbiz.de/10009685446
instruments and the remuneration derived therefrom are characterized by a neat division into dividend-generating equity and …, Germany, Italy and the Netherlands as well as in the relevant tax treaties and EU Directives. Moreover, based on selected … options that are in line with the dichotomous debt-equity framework, as he/she suggests the coordination of either tax …
Persistent link: https://www.econbiz.de/10014016291
Background: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical...
Persistent link: https://www.econbiz.de/10010530072
Persistent link: https://www.econbiz.de/10013279337